跳至主要内容
临床试验/NCT03427021
NCT03427021终止早期 1 期

A Randomized Study to Establish the Efficacy of Oral Ice Exposure During Oxaliplatin Infusion in Preventing Oral Cold Sensitivity

Abramson Cancer Center at Penn Medicine1 个研究点 分布在 1 个国家目标入组 65 人开始时间: 2017年2月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
早期 1 期
状态
终止
入组人数
65
试验地点
1
主要终点
overall intraoral cold sensitivity score

研究概览

简要总结

The main purpose of this study is to evaluate whether exposure to ice chips in the mouth (oral ice chips) during oxaliplatin treatment prevents or reduces symptoms of cold sensitivity.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Individuals ≥18 years of age will be enrolled.
  • Patients must have histologic confirmation of a solid tumor malignancy that will be treated with a regimen that contains full-dose oxaliplatin.
  • Patients may be receiving treatment in the neoadjuvant, adjuvant or metastatic setting.
  • Patients must be treatment-naïve to platinum-agents at the time of enrollment. Prior treatment with non-platinum agents is permitted.

排除标准

  • Any active intraoral infection, including yeast infection (thrush) or active oral herpes simplex virus at the time of enrollment.
  • Patients may not have dentures.
  • Patients may not have a disorder that may result in altered taste sensation at baseline. This includes but is not limited to: persistent dry mouth.

研究组 & 干预措施

Arm A

Experimental

will be treated with consistent exposure to oral ice

干预措施: Oxaliplatin (Drug)

Arm B

Active Comparator

Will not be treated with consistent exposure to oral ice.

干预措施: Oxaliplatin (Drug)

结局指标

主要结局

overall intraoral cold sensitivity score

时间窗: a minimum of four cycles (2 months) and a maximum of 12 cycles (6 months)

graded 0 to 4

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

A Randomized Study to Establish the Efficacy of Oral... | 临床试验